BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
McKinsey
Chubb
Federal Trade Commission
UBS
AstraZeneca
Moodys
Farmers Insurance
Healthtrust
Julphar

Generated: January 21, 2018

DrugPatentWatch Database Preview

CEFAZOLIN AND DEXTROSE Drug Profile

« Back to Dashboard

Which patents cover Cefazolin And Dextrose, and when can generic versions of Cefazolin And Dextrose launch?

Cefazolin And Dextrose is a drug marketed by B Braun and is included in one NDA.

The generic ingredient in CEFAZOLIN AND DEXTROSE is cefazolin sodium. There are twenty-seven drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the cefazolin sodium profile page.
Drug patent expirations by year for CEFAZOLIN AND DEXTROSE
Pharmacology for CEFAZOLIN AND DEXTROSE
Medical Subject Heading (MeSH) Categories for CEFAZOLIN AND DEXTROSE

US Patents and Regulatory Information for CEFAZOLIN AND DEXTROSE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B Braun CEFAZOLIN AND DEXTROSE cefazolin sodium INJECTABLE;INJECTION 050779-002 Jul 27, 2000 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
B Braun CEFAZOLIN AND DEXTROSE cefazolin sodium INJECTABLE;INJECTION 050779-003 Jan 13, 2012 RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
B Braun CEFAZOLIN AND DEXTROSE cefazolin sodium INJECTABLE;INJECTION 050779-001 Jul 27, 2000 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
Express Scripts
Argus Health
US Department of Justice
Moodys
Deloitte
AstraZeneca
Accenture
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot